Institut Fuer Frauengesundheit
Clinical trials sponsored by Institut Fuer Frauengesundheit, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Breast cancer drug adherence under the microscope: will patients stick with treatment? Results expected Sep 2026 (estimated)
-
Coaching may boost cancer pill adherence in new study
Disease control Not yet recruitingThis study looks at whether extra education and counseling helps women with HR+/HER2- early breast cancer take their prescribed medication, abemaciclib, more consistently. About 257 women will either receive standard care or additional coaching. The main goal is to see if coachin…
Sponsor: Institut fuer Frauengesundheit • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Blood test maps hidden resistance signal in advanced breast cancer
Diagnosis Not yet recruitingPeople with hormone receptor-positive, HER2-negative advanced breast cancer often start treatment with a CDK4/6 inhibitor plus an aromatase inhibitor. Over time, some tumors develop an ESR1 mutation that can make the aromatase inhibitor stop working. This study takes blood sample…
Sponsor: Institut fuer Frauengesundheit • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC